PMID: 41834765

Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression.

Ahmed Muhammad, Hassan Muhammad, Tahir Muhammad, Hussain Muhammad, Islam Faisal, Khan Ghulam Taha, Ahsan Muhammad, Bin Shafiq Shaheer, Ibrahim Ahmed, Uddin Ammad

Diabetes, obesity & metabolism · 2026

Vol. 28, Issue 6, pp. 4828-4836

View on PubMed DOI

This entry links to third-party literature. For research use only.

SemaglutideHumansGlucagon-Like PeptidesObesityAnti-Obesity AgentsWeight LossTreatment OutcomeRandomized Controlled Trials as TopicBlood Glucose

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.